432 related articles for article (PubMed ID: 32557809)
1. Osteocytes control myeloid cell proliferation and differentiation through Gsα-dependent and -independent mechanisms.
Azab E; Chandler KB; Uda Y; Sun N; Hussein A; Shuwaikan R; Lu V; Costello CE; McComb ME; Divieti Pajevic P
FASEB J; 2020 Aug; 34(8):10191-10211. PubMed ID: 32557809
[TBL] [Abstract][Full Text] [Related]
2. Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity.
Fulzele K; Dedic C; Lai F; Bouxsein M; Lotinun S; Baron R; Divieti Pajevic P
Bone; 2018 Dec; 117():138-148. PubMed ID: 30266511
[TBL] [Abstract][Full Text] [Related]
3. Myelopoiesis is regulated by osteocytes through Gsα-dependent signaling.
Fulzele K; Krause DS; Panaroni C; Saini V; Barry KJ; Liu X; Lotinun S; Baron R; Bonewald L; Feng JQ; Chen M; Weinstein LS; Wu JY; Kronenberg HM; Scadden DT; Divieti Pajevic P
Blood; 2013 Feb; 121(6):930-9. PubMed ID: 23160461
[TBL] [Abstract][Full Text] [Related]
4. Connexin 43 and cell culture substrate differentially regulate OCY454 osteocytic differentiation and signaling to primary bone cells.
Hoppock GA; Buettmann EG; Denisco JA; Goldscheitter GM; Condyles SN; Juhl OJ; Friedman MA; Zhang Y; Donahue HJ
Am J Physiol Cell Physiol; 2023 Oct; 325(4):C907-C920. PubMed ID: 37602413
[TBL] [Abstract][Full Text] [Related]
5. Connexin 43 and Cell Culture Substrate Differentially Regulate OCY454 Osteocytic Differentiation and Signaling to Primary Bone Cells.
Hoppock GA; Buettmann EG; Denisco JA; Goldscheitter GM; Condyles SN; Juhl OJ; Friedman MA; Zhang Y; Donahue HJ
bioRxiv; 2023 Jun; ():. PubMed ID: 37425674
[TBL] [Abstract][Full Text] [Related]
6. OCY454 Osteocytes as an in Vitro Cell Model for Bone Remodeling Under Mechanical Loading.
Xu LH; Shao H; Ma YV; You L
J Orthop Res; 2019 Aug; 37(8):1681-1689. PubMed ID: 30977540
[TBL] [Abstract][Full Text] [Related]
7. Osteocyte-Secreted Wnt Signaling Inhibitor Sclerostin Contributes to Beige Adipogenesis in Peripheral Fat Depots.
Fulzele K; Lai F; Dedic C; Saini V; Uda Y; Shi C; Tuck P; Aronson JL; Liu X; Spatz JM; Wein MN; Divieti Pajevic P
J Bone Miner Res; 2017 Feb; 32(2):373-384. PubMed ID: 27653320
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.
Delgado-Calle J; Anderson J; Cregor MD; Hiasa M; Chirgwin JM; Carlesso N; Yoneda T; Mohammad KS; Plotkin LI; Roodman GD; Bellido T
Cancer Res; 2016 Mar; 76(5):1089-100. PubMed ID: 26833121
[TBL] [Abstract][Full Text] [Related]
9. Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways.
Ramaswamy G; Kim H; Zhang D; Lounev V; Wu JY; Choi Y; Kaplan FS; Pignolo RJ; Shore EM
Sci Rep; 2017 Mar; 7():45140. PubMed ID: 28338087
[TBL] [Abstract][Full Text] [Related]
10. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro.
Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI
J Cell Biochem; 2019 Oct; 120(10):16741-16749. PubMed ID: 31106449
[TBL] [Abstract][Full Text] [Related]
11. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.
Kitaura H; Marahleh A; Ohori F; Noguchi T; Shen WR; Qi J; Nara Y; Pramusita A; Kinjo R; Mizoguchi I
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708317
[TBL] [Abstract][Full Text] [Related]
12. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro.
Al-Dujaili SA; Lau E; Al-Dujaili H; Tsang K; Guenther A; You L
J Cell Biochem; 2011 Sep; 112(9):2412-23. PubMed ID: 21538477
[TBL] [Abstract][Full Text] [Related]
14. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
Allison H; Holdsworth G; McNamara LM
BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging.
Davis HM; Pacheco-Costa R; Atkinson EG; Brun LR; Gortazar AR; Harris J; Hiasa M; Bolarinwa SA; Yoneda T; Ivan M; Bruzzaniti A; Bellido T; Plotkin LI
Aging Cell; 2017 Jun; 16(3):551-563. PubMed ID: 28317237
[TBL] [Abstract][Full Text] [Related]
16. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
[TBL] [Abstract][Full Text] [Related]
18. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis.
Hayashida C; Ito J; Nakayachi M; Okayasu M; Ohyama Y; Hakeda Y; Sato T
J Biol Chem; 2014 Apr; 289(16):11545-11555. PubMed ID: 24610813
[TBL] [Abstract][Full Text] [Related]
19. The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss.
Shandala T; Shen Ng Y; Hopwood B; Yip YC; Foster BK; Xian CJ
J Cell Physiol; 2012 Jul; 227(7):2889-97. PubMed ID: 21938727
[TBL] [Abstract][Full Text] [Related]
20. IL-1β differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets.
Cao Y; Jansen ID; Sprangers S; Stap J; Leenen PJ; Everts V; de Vries TJ
J Leukoc Biol; 2016 Sep; 100(3):513-23. PubMed ID: 26957213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
